Treatment of Graves' Hyperthyroidism With Selenium Plus Methimazole

• Status: Completed
• Trial end date: 2015-12-01
• Target enrollment: 0
• Participant gender: All

Summary

Evaluation of the efficacy of the combined treatment (methimazole plus selenium) in the control of hyperthyroidism as compared to methimazole alone in 30 Graves' disease (GD) untreated patients.

• Phase: N/A
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: University of Pisa
• Treatments: Methimazole; Selenium

Criteria

Inclusion Criteria:

• Hyperthyroid untreated Graves' disease patients

Exclusion Criteria:

• Hyperthyroid treated Graves' disease patients